A compilation of CosmeticsDesign-Europe’s most-read news from March 2020 shows interest in scientific and brand innovation, as well as the ongoing industry response to the coronavirus (COVID-19) pandemic.
Certain Latin American plants listed in the European Commission’s cosmetic ingredient database CosIng are rich in antioxidants or have protective properties, presenting promise for beauty innovation, say researchers.
Beauty products considered preventative and safe will see a sharp rise in demand during the ongoing coronavirus outbreak, driving clear and lasting change across personal care, says Mintel.
Personal care major Unilever has developed a microbiome balancing formula using a prebiotic binder for lotions, body washes, deodorants and toothpastes, among other products.
CBD beauty is poised to take off across Europe, despite complex regulatory hurdles, and the UK, hemp, and medical cosmetics are key areas of promise, says a cannabis expert.
The French Federation for Beauty Companies (FEBEA) will mobilise its network to ramp up production of hygiene and hydroalcoholic products, following calls from the Ministry of Health to assist amid the ongoing COVID-19 outbreak.
Beauty major L’Oréal has ramped up mass production of hydroalcoholic gels to support European health authorities amid the coronavirus outbreak and pledged €1m to associations working with those in need.
American CBD specialist Medterra will further expand presence in Europe with the launch of several beauty and skin care products this year, delving deeper into a space it sees significant opportunity in.
International beauty major L’Oréal has developed advanced sunscreen formulations that provide increased protection, improved sensorial experience, enhanced appearance and skin whitening.
There is significant potential to develop probiotics in the beauty space, particularly targeting anti-ageing, Generation Z and women, according to Lumina Intelligence.
Conscious consumerism is here to stay and as the fast-paced clean and ethical beauty trend takes its grip, industry needs to start delivering on all fronts – overcoming lab and regulatory hurdles along the way.
There is plenty of activity in probiotic topical formulations targeting the skin microbiome, but could ‘beauty from within’ using supplements be a strong alternative? Experts believe so.
Royal DSM has signed a commercial agreement with Belgian life sciences startup S-Biomedic to develop and commercialise a skin care active that uses probiotic technology to treat acne.
Unilever has reported a net profit decline for 2019, with a clear slowdown in North Africa, Middle East and Turkey, but says prestige beauty and skin care should stimulate future growth.
